Trading access on the OTCQB is a pivotal gateway to U.S. trading. The firm also announced it received Depository Trust Company eligibility, which expands the stock’s reach to an even wider audience of potential investors.
According to NurExone CEO Dr. Lior Shaltiel, “Expanding our investor base will accelerate our efforts in developing solutions and therapies for the hundreds of thousands of patients worldwide suffering from traumatic spinal cord injuries.”
Canadian shares were trading up at $0.64 in morning trade.
Copyright © 2024 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com’s content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
]]>